Robert Wasserman
Stock Analyst at Benchmark
(3.31)
# 1,078
Out of 4,479 analysts
81
Total ratings
41.43%
Success rate
4.26%
Average return
Main Sectors:
19 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LGND Ligand Pharmaceuticals | Reiterates: Buy | $95 | $84.49 | +12.45% | 7 | Jun 28, 2024 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $50 → $60 | $51.62 | +16.23% | 6 | Jun 25, 2024 | |
| EBS Emergent BioSolutions | Reiterates: Buy | $8 | $7.86 | +1.78% | 11 | Jun 21, 2024 | |
| PRLB Proto Labs | Reiterates: Buy | $45 | $29.97 | +50.15% | 6 | May 29, 2024 | |
| INTS Intensity Therapeutics | Reiterates: Speculative Buy | $12 | $4.92 | +143.90% | 5 | May 16, 2024 | |
| NEPH Nephros | Reiterates: Speculative Buy | $5 | $2.06 | +142.72% | 2 | May 15, 2024 | |
| OABI OmniAb | Reiterates: Buy | $8 | $3.66 | +118.58% | 5 | May 14, 2024 | |
| BLFS BioLife Solutions | Upgrades: Buy | $25 | $20.89 | +19.67% | 5 | May 13, 2024 | |
| ITGR Integer Holdings | Reiterates: Buy | $130 | $116.01 | +12.06% | 5 | May 10, 2024 | |
| CDXS Codexis | Reiterates: Buy | $9 | $2.91 | +209.28% | 5 | May 3, 2024 | |
| TECH Bio-Techne | Reiterates: Buy | $95 | $71.55 | +32.77% | 4 | May 2, 2024 | |
| IPA ImmunoPrecise Antibodies | Reiterates: Speculative Buy | $5 | $1.00 | +402.51% | 4 | Mar 15, 2024 | |
| ATHE Alterity Therapeutics | Reiterates: Speculative Buy | $4 | $1.80 | +122.22% | 1 | Mar 7, 2024 | |
| PCSA Processa Pharmaceuticals | Reiterates: Speculative Buy | $4 | $2.00 | +100.00% | 1 | Mar 6, 2024 | |
| ABCL AbCellera Biologics | Upgrades: Buy | n/a | $2.78 | - | 3 | Feb 22, 2024 | |
| RGEN Repligen | Downgrades: Hold | n/a | $121.99 | - | 2 | Dec 4, 2023 | |
| ANEB Anebulo Pharmaceuticals | Reiterates: Speculative Buy | $8 | $2.56 | +212.50% | 4 | Oct 3, 2023 | |
| FBIO Fortress Biotech | Reiterates: Speculative Buy | $75 | $1.63 | +4,501.23% | 2 | Apr 6, 2023 | |
| DHR Danaher | Downgrades: Hold | n/a | $240.69 | - | 3 | Oct 24, 2022 |
Ligand Pharmaceuticals
Jun 28, 2024
Reiterates: Buy
Price Target: $95
Current: $84.49
Upside: +12.45%
Halozyme Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $50 → $60
Current: $51.62
Upside: +16.23%
Emergent BioSolutions
Jun 21, 2024
Reiterates: Buy
Price Target: $8
Current: $7.86
Upside: +1.78%
Proto Labs
May 29, 2024
Reiterates: Buy
Price Target: $45
Current: $29.97
Upside: +50.15%
Intensity Therapeutics
May 16, 2024
Reiterates: Speculative Buy
Price Target: $12
Current: $4.92
Upside: +143.90%
Nephros
May 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
OmniAb
May 14, 2024
Reiterates: Buy
Price Target: $8
Current: $3.66
Upside: +118.58%
BioLife Solutions
May 13, 2024
Upgrades: Buy
Price Target: $25
Current: $20.89
Upside: +19.67%
Integer Holdings
May 10, 2024
Reiterates: Buy
Price Target: $130
Current: $116.01
Upside: +12.06%
Codexis
May 3, 2024
Reiterates: Buy
Price Target: $9
Current: $2.91
Upside: +209.28%
Bio-Techne
May 2, 2024
Reiterates: Buy
Price Target: $95
Current: $71.55
Upside: +32.77%
ImmunoPrecise Antibodies
Mar 15, 2024
Reiterates: Speculative Buy
Price Target: $5
Current: $1.00
Upside: +402.51%
Alterity Therapeutics
Mar 7, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $1.80
Upside: +122.22%
Processa Pharmaceuticals
Mar 6, 2024
Reiterates: Speculative Buy
Price Target: $4
Current: $2.00
Upside: +100.00%
AbCellera Biologics
Feb 22, 2024
Upgrades: Buy
Price Target: n/a
Current: $2.78
Upside: -
Repligen
Dec 4, 2023
Downgrades: Hold
Price Target: n/a
Current: $121.99
Upside: -
Anebulo Pharmaceuticals
Oct 3, 2023
Reiterates: Speculative Buy
Price Target: $8
Current: $2.56
Upside: +212.50%
Fortress Biotech
Apr 6, 2023
Reiterates: Speculative Buy
Price Target: $75
Current: $1.63
Upside: +4,501.23%
Danaher
Oct 24, 2022
Downgrades: Hold
Price Target: n/a
Current: $240.69
Upside: -